Fujifilm Diosynth Biotechnologies
GPTKB entity
Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquired |
gptkb:Merck_KGa_A's_biopharmaceutical_manufacturing_facility
|
| gptkbp:collaborates_with |
various pharmaceutical companies
|
| gptkbp:employs |
over 1,000 people
|
| gptkbp:focuses_on |
biologics
|
| gptkbp:founded |
gptkb:2001
|
| gptkbp:has_location |
gptkb:North_Carolina,_USA
gptkb:Denmark |
| gptkbp:has_part |
gptkb:supply_chain_management
laboratories manufacturing plants research and development teams technical support services quality control systems project management teams regulatory compliance teams c GMP facilities |
| gptkbp:headquartered_in |
gptkb:Teesside,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fujifilm Diosynth Biotechnologies
|
| gptkbp:is_active_in |
gptkb:gene_therapy
monoclonal antibody production vaccine production |
| gptkbp:is_committed_to |
sustainability
|
| gptkbp:is_involved_in |
gptkb:customer_support
quality assurance risk management clinical trials process optimization product development supply chain optimization product lifecycle management scale-up processes regulatory submissions formulation development post-market surveillance technology transfer market access strategies bioprocessing analytical testing commercial manufacturing cell line development clinical supply management fill and finish services |
| gptkbp:is_known_for |
flexible manufacturing solutions
high-quality biomanufacturing |
| gptkbp:is_part_of |
gptkb:Fujifilm_Corporation
|
| gptkbp:is_recognized_for |
innovation in biomanufacturing
|
| gptkbp:operates_in |
global market
|
| gptkbp:parent_company |
gptkb:Fujifilm
|
| gptkbp:provides |
contract development and manufacturing services
|
| gptkbp:services_provided |
cell culture
process development protein production |
| gptkbp:specializes_in |
biopharmaceutical manufacturing
|
| gptkbp:bfsParent |
gptkb:Fuji_Film
gptkb:Cytiva |
| gptkbp:bfsLayer |
6
|